Skip to main content
. 2011 Feb 15;52(4):540–546. doi: 10.1093/cid/ciq195

Figure 1.

Figure 1.

Schematic of once-daily ART study design. 3TC, lamivudine; ATT, antituberculosis treatment; ART, antiretroviral therapy; CD4, CD4+ cell count; ddI, didanosine; EFV, efavirenz; exam, examination; HIV, human immunodeficiency virus; LFT, liver function test; NVP, nevirapine; RMP, rifampin; TB, tuberculosis VL, viral load.